EP1235604A1 — Medicament dispenser
Assigned to Glaxo Group Ltd · Expires 2002-09-04 · 24y expired
What this patent protects
There is provided a medicament dispenser (2) having a body, a medicament container (4), dose-liberating means (10), an energy store (20) for actuating said dose-liberating means and trigger means (16) for directly or indirectly releasing the energy store (20), wherein the trigger…
USPTO Abstract
There is provided a medicament dispenser (2) having a body, a medicament container (4), dose-liberating means (10), an energy store (20) for actuating said dose-liberating means and trigger means (16) for directly or indirectly releasing the energy store (20), wherein the trigger means (16) comprises a trigger coupling (28). The coupling (28) is reversibly deformable in response to the application of non-mechanical energy thereto. The non-mechanical energy may comprise heat energy, electrical current energy, electrical field energy or magnetic field energy.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.